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Natural killer T (NKT) cells recognize glycolipids pre-
sented by CD1d. The first antigen described,
a-galactosyl ceramide (aGalCer), is a potential anti-
cancer agent whose activity depends upon IFN-g
secretion. We report two analogs of aGalCer based
on a naturally occurring glycosphingolipid, plakoside
A. These compounds induce enhanced IFN-g that
correlates with detergent-resistant binding to CD1d
and an increased stability of the lipid-CD1d com-
plexes on antigen-presenting cells. Structural anal-
ysis on one of the analogs indicates that it is more
deeply bound inside the CD1d groove, suggesting
tighter lipid-CD1d interactions. To our knowledge,
this is the first example in which structural informa-
tion provides an explanation for the increased lipid-
CD1d stability, likely responsible for the Th1 bias.
We provide insights into the mechanism of IFN-g-
inducing compounds, and because our compounds
activate human NKT cells, they could have thera-
peutic utility.
INTRODUCTION
Natural killer T cells with an invariant T cell receptor a chain
(iNKT cells) recognize microbial and synthetic glycolipids bound
to and presented by CD1d. aGalCer (Figure 1) was identified as
the lead anticancer candidate in structure activity relationship
studies around Agelasphin 9b, a natural product isolated from
the Agelas genus of marine sponges (Morita et al., 1995).
aGalCer subsequently has been the key glycolipid used to eluci-
date the role of iNKT cells in the immune system (Bendelac et al.,
2007). The antitumor activity of this compound depends on
IFN-g secretion, much of which is produced by natural killer cells
that are activated downstream of antigen-specific iNKT cell
stimulation (Yu and Porcelli, 2005). Interestingly, analogs closely1620 Chemistry & Biology 18, 1620–1630, December 23, 2011 ª2011related to aGalCer can elicit different cytokine profiles in
the immune response. For example, in a number of cases, en-
hanced IL-4 secretion is observed (Oki et al., 2004; Yu et al.,
2005). Immunologists refer to outcomes of predominant IL-4
production as T helper type 2 (Th2) responses. Other analogs
induce amore IFN-g-biased or Th1 response, which is important
for anticancer immunity and host defense against infectious
agents. Whereas there has been a strong interest in developing
Th1-biasing glycolipid antigens for iNKT cells, relatively few anti-
gens fit into this category (Aspeslagh et al., 2011; Chang et al.,
2007; Li et al., 2009; Lin et al., 2010; Lu et al., 2006; Tashiro
et al., 2010). The prototypical Th1-biasing glycosphingolipid,
known as C-glycoside, has the O glycosidic bond replaced
with a carbon (Schmieg et al., 2003). Whereas it effectively leads
to IFN-g synthesis in vivo in mice, C-glycoside does not stimu-
late human iNKT cells (Arora et al., 2011). Therefore, whereas
a number of glycolipid antigens related to aGalCer with inter-
esting properties have been characterized, there is a need for
Th1-biasing compounds that strongly activate human iNKT
cells.
In a search for additional glycolipids that induce a Th1-polar-
ized iNKT cell response, we considered natural products similar
to aGalCer, specifically, plakoside A (Figure 1), a glycosphingoli-
pid isolated from the marine sponge, Plakortis simplex (Costan-
tino et al., 1997). The ceramide of plakoside A shares structural
features with aGalCer, as well as similarities to a cyclopropa-
nated glycolipid isolated from Sphingomonas witichii. We syn-
thesized two plakoside A analogs with either a cyclopropanated
acyl chain or sphingoid base and evaluated their ability to acti-
vate mouse and human iNKT cells. We characterized the glyco-
lipids in terms of their antigenic responses, stability of CD1d-
binding, T cell antigen receptor (TCR) binding kinetics, and the
crystal structure of one glycolipid bound in the CD1d-TCR
complex. Our data suggest that a more stable glycolipid-CD1d
interaction in vivo, driven in part by a more stable binding of
the antigen in the CD1d groove, is an important determinant of
a Th1-skewed cytokine response. Therefore, this comprehen-
sive analysis allows us to link the enhanced response elicited
by these compounds to biochemical and structural features of
their interactions.Elsevier Ltd All rights reserved
Figure 1. Structures of Immunostimu-
latory Natural Glycolipids, a-GalCer and
C-glycoside
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Synthetic Strategies
Both the sphingoid base and the acyl chain of plakoside A have
unique features in comparison to aGalCer and its analogs. With
this in mind, we decided to evaluate separately the influence on
iNKT cell stimulation of the sphingoid base and acyl chain moie-
ties of plakoside A (Figure 1). Compound SMC124 contains a ce-
ramide that couples the acyl chain of aGalCer with the sphingoid
base of plakoside A. Compound EF77 has an acyl chain similar to
that of plakoside A and links this to the phytosphingosine of
aGalCer. We did not include the a-carbon OH group on the
acyl chain of plakoside A in EF77 because it simplified access,
and the studies with agelasphin 9b had shown that this a-OH
group was not essential for activity (Morita et al., 1995). A
nonasymmetric, syn-selective cyclopropanation was done for
SMC124 and EF77 because this too simplified the syntheses
for initial evaluations. It is noteworthy that the sphingoid baseFigure 2. Strategies for the Syntheses of Plakoside A/aGalCer Hybrid Compounds SMC124 an
Chemistry & Biology 18, 1620–1630, December 23, 2011 ªof SMC124 is longer than any of the
a-galactosyl ceramides that have been
assessed to date, and we speculated
that the increased chain length could
influence CD1d binding.
With the increased interest in glycolipid
antigens for iNKT cells, aspects of their
synthesis have become more stream-
lined. For example, the first published
synthesis of aGalCer had a longest linear
sequence of more than 15 steps (Morita
et al., 1995), with more steps required to
make key intermediates. On the otherhand, Gervay-Hague and colleagues recently reported a three-
step synthesis of aGalCer from commercially available starting
materials (Du et al., 2007). In spite of the significant advances
in synthesis, glycolipids with variations in the sugar, acyl chain,
or sphingoid base still represent challenging targets. The two
most common strategies for glycolipid synthesis involve either
glycosylation of a ceramide or coupling of a donor sugar with
some form of a sphingoid base, followed by acylation. The
former approach was used to synthesize SMC124, whereas
the latter was employed for EF77 (Figure 2).
Plakosides are iNKT Cell Agonists
To analyze the biological activity of SMC124 and EF77 in vitro,
we utilized mouse iNKT cell hybridomas and human iNKT cell
lines. We first confirmed the ability of SMC124 and EF77 to stim-
ulate immortalized iNKT cells (hybridomas) using the B lym-
phoma cell line A20 expressing surface mouse CD1d molecules
as antigen presenting cells (APC). Regardless of if thed EF77
2011 Elsevier Ltd All rights reserved 1621
Figure 3. Immune Responses to Plakoside A Analogs
(A) A20 cells transfected with CD1d and pulsed with the indicated glycolipid
concentrations were cultured with iNKT cell hybridoma 1.2, and IL-2 cytokine
levels in the supernatant were quantified by ELISA after 16 hr of culture.
(B) Same as (A), except antigen presentation was carried out on CD1d-coated
plates and incubated with the indicated glycolipids concentrations. Similar
results were obtained in (A) and (B) with additional iNKT cell hybridomas.
(C) Peripheral blood mononuclear cells were pulsed with 100 ng/ml of the
indicated glycolipids and cultured overnight. Cells were washed and cocul-
tured with human iNKT cell lines for 24 hr. Cytokine levels for human GM-CSF
were measured in the supernatant using ELISA. Representative data from one
of 3–5 experiments performed in triplicate wells using multiple human cell lines
are shown. See also Figure S1.
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both plakoside A analogs stimulated two iNKT cell hybridomas
to similar levels (Figure 3, Figure S1). iNKT cell hybridoma 1.4,
has an identical TCR a chain to hybridoma 1.2, but it utilizes
Vb10 instead of the Vb8.2 segment that is much more common
in iNKT cells (Brossay et al., 1998). To determine whether the
stimulatory capacity of SMC124 and EF77 required internaliza-
tion into cells, and perhaps lysosomal processing, we tested
the ability of these glycosphingolipids to load onto immobilized
CD1d molecules. These molecules were then tested to deter-
mine if they stimulate iNKT cell hybridomas in an APC-free assay
measuring IL-2 release, a well-characterized bioassay for TCR
engagement. At a concentration of 100 ng/ml, EF77 elicited a
strong TCR-dependent response from the 1.2 hybridoma,
whereas a 10-fold higher lipid concentration of SMC124 was
required to elicit a similar response (Figure 3B). Similar results
were observed using iNKT cell hybridoma 1.4 (Figure S1). These
data clearly demonstrate that theCD1dmolecule can accommo-
date the cyclopropane group on either chain of the lipid and that
the CD1d-bound antigens remain stimulatory for iNKT cell
hybridomas.
We and others have observed that the first described Th1-
skewing glycosphingolipid, C-glycoside, does not stimulate
human iNKT cells (Li et al., 2009). To determine if human iNKT
cells respond to SMC124 or EF77, we utilized expanded human
iNKT cell lines as responders and autologous peripheral blood1622 Chemistry & Biology 18, 1620–1630, December 23, 2011 ª2011mononuclear cells (PBMC) pulsed with lipids as APCs. Periph-
eral blood mononuclear cells were incubated with SMC124,
EF77, C-glycoside, or aGalCer and then cocultured with human
iNKT cell lines. GM-CSF secretion was analyzed because it has
been previously demonstrated to be a sensitive measurement
of TCR-mediated human iNKT cell activation. As previously
reported, aGalCer stimulated human iNKT cells, whereas
the previously known Th1-skewing lipid in mice, C-glycoside,
did not. Interestingly, SMC124 and EF77 induced significant
amounts of GM-CSF secretion in all cell lines tested, although
EF77 tended to be more potent for several of the cell lines (Fig-
ure 3C, Figure S1).
In Vivo Activation of iNKT Cells
To determine if the plakoside A analogs activate iNKT cells
in vivo, C57BL/6J mice were injected with lipid antigens, and
sera were analyzed at various time points for IFN-g (Figures 4A
and 4B) and IL-4 (Figure S2) by ELISA. It has been previously re-
ported that IL-4 secretion peaks within two hours of aGalCer
injection, with IFN-g reaching a maximum level somewhat later
(Matsuda et al., 2003; Schmieg et al., 2003). The Th1-biasing
antigen C-glycoside causes a peak of IFN-g by 6–12 hr that is
sustained longer and up to 36 hr. The systemic IFN-g in the
sera at 6 hr and later following either aGalCer or C-glycoside is
primarily the result of secondary activation of natural killer cells
downstream of iNKT cells (Matsuda et al., 2003; Yu and Porcelli,
2005). Two hours after injection of SMC124 or EF77, serum cyto-
kine levels for IFN-g were 3-fold lower than in aGalCer-injected
mice (Figure 4A). Similar to C-glycoside, plakoside A analogs
elicited lower IL-4 sera levels compared to aGalCer (Figure S2).
Strikingly, SMC124- and EF77-injected mice consistently had
seven- to eight-fold higher serum IFN-g levels 22 hr post-lipid
injection compared to either C-glycoside or aGalCer in six inde-
pendent experiments (Figure 4B).
It has been previously reported that some glycolipids have
the potential of inducing increased levels of trans activation
of several other cell types, including natural killer cells (Carnaud
et al., 1999; Kawakami et al., 2001; Kitamura et al., 1999;
Parekh et al., 2004). To address this, mice were analyzed by
intracellular cytokine staining 22 hr after lipid injection for
IFN-g production by natural killer cells. In agreement with the
data from sera, natural killer cells from plakoside A analogs-
injected mice produced more IFN-g, as measured on a per
cell basis by the mean fluorescent intensity (MFI) or when the
percentage of IFN-g + natural killer (NK1.1+ TCRb) cells in
the spleen was assessed (Figures 4C and 4D). Similar results
were observed when cells from the liver were analyzed (data
not shown).
The mechanism of aGalCer and C-glycoside natural killer cell
trans activation is dependent on the lipid being presented on
CD1d to the iNKT cell receptor leading to CD40-mediated
IL-12 production by DCs (Carnaud et al., 1999; Fujii et al.,
2006; Kitamura et al., 1999). IL-12 in turn enhances natural
killer-cell-mediated IFN-g production. To confirm that the mech-
anism of trans activation by the plakoside A analogs is mediated
through IL-12, we analyzed IL-12 serum levels from mice
following lipid antigen injection. Correlating with the higher
IFN-g levels observed in the sera, IL-12 in the sera of mice that
received SMC124 or EF77 was higher and sustained longerElsevier Ltd All rights reserved
Figure 4. In Vivo Responses to Plakoside A Analogs
C57Bl/6 mice were injected with 2 mg of the indicated antigen, and sera were analyzed at the indicated time points.
(A and B) Serum samples were measured for cytokine levels by ELISA. Data are representative of six independent experiments of two or three mice per group.
Error bars represent ±SEM (C and D)Mice were sacrificed at 22 hr and TCRb, NK1.1+ natural killer cells were analyzed for the production of IFN-g by intracellular
cytokine staining.
(C) Percentage of IFN-g+ natural killer cells directly ex vivo 22 hr postinjection of lipid (open histogram) compared with PBS injected control (shaded histogram).
Histograms are representative plots of aminimumof three independent experiments of 3–5mice per group. Numbers represent percentage of IFN-g+ natural killer
cells.
(D) MFI scatter plot of IFN-g intracellular fluorescence from 3–5 mice per group. Data are representative of four independent experiments.
(E) Serum samples were measured for IL-12p70 cytokine levels by ELISA. Data are representative of two independent experiments of three mice per group. Error
bars represent ±SEM. Statistically significant differences using the equal variance unpaired Student t test are indicated with an asterisk (*p% 0.001) comparing
aGalCer to either SMC124 or EF77. See also Figure S2.
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the absence of IL-12 receptor expression, IFN-g was no longer
observed at 22 hr postinjection (Figure S2).Chemistry & Biology 18, 1620–163Plakosides Have Prolonged In Vivo Activity
The ability of compounds to skew Th1 responses is correlated
with loading into the groove of CD1d in endocytic compartments0, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1623
Figure 5. Stability of Lipid/CD1d Com-
plexes
(A) Plot of detergent resistance of CD1d/glyco-
lipid/antibody complexes formed with SMC124,
EF77, and known Th1- and Th2-biasing aGalCer
agonists on JAWS II DCs.
(B and C) C57Bl/6 mice were injected with 2 mg of
the indicated lipid antigens and CD11c+ DC were
enriched using magnetic bead isolation at 2 (B)
and 22 (C) hr postinjection. Varying number of
enriched DC were cultured with the 1.2 Va14 iNKT
cell hybridoma overnight and IL-2 in the superna-
tant quantified by ELISA. Data are plotted as the
number of enriched DCs per well versus IL-2
(pg/ml). Data are representative of two indepen-
dent experiments. Error bars represent ±SEM of
two or three mice per condition.
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selectively in lipid raft microdomains of the plasma membrane
(Im et al., 2009). Recently a rapid, fluorescence-based assay for
estimating the extent of lipid raft localization of CD1d/aGalCer
complexes was developed for the efficient screening of com-
pounds that skew Th1 cytokine responses (Arora et al., 2011).
This assay uses fluorescently labeled antibodies that bind to
CD1d only when it is loaded with aGalCer or closely related
analogs, and it measures the kinetics of the loss of fluorescence
associatedwith thecells after exposure tomilddetergentconcen-
trations. Since plasma membrane lipid rafts microdomains are
detergent resistant,CD1d/glycolipid agonist complexes localized
in lipid rafts cannot be extracted, and a minimal decrease in fluo-
rescence intensity is observed over time. In contrast, for the
CD1d/glycolipid agonist complexes that are excluded from lipid
rafts, the MFI decreases sharply following the Tx-100 addition.
Utilizing this method, we observed that CD1d complexes loaded
with either SMC124 or EF77 were stable to detergent to a similar
extent as aGalCer or C-glycoside (Figure 5A). This is in sharp
contrast to aGalCer C20:2, an analog with an unsaturated acyl
chain that is Th2-biasing (Arora et al., 2011).
Another striking feature of the Th1-biasing antigen C-glyco-
side is that it has a prolonged biological stability in vivo, meaning
that APC from mice injected hours earlier with C-glycoside
have an enhanced ability to stimulate iNKT cells compared
to aGalCer. To test if the plakoside A analogs also have a pro-
longed ability to stimulate iNKT cells in vivo, mice were injected
with glycosphingolipids, and APCs were harvested at various
time points and tested directly ex vivo for their ability to stimu-
late iNKT cell hybridomas. Selected CD11c+ dendritic cells
(DC; >80% pure) isolated from lipid or DMSO-control-injected1624 Chemistry & Biology 18, 1620–1630, December 23, 2011 ª2011 Elsevier Ltd All rights remice obtained at 2 and 22 hr postinjection
were cocultured at increasing concen-
trations with a fixed number of iNKT
cell hybridomas. Dendritic cells isolated
from aGalCer-injected mice were able to
activate the hybridoma at 2 and 22 hr
postinjection, as measured by IL-2 secre-
tion, although at 22 hr the stimulatory
capacity of the DC declined by approxi-
mately 50% (Figures 5B and 5C). At22 hr postinjection, EF77 and SMC124 retained a nearly undi-
minished ability to activate the iNKT cell hybridomas compared
with 2 hr after injection (Figures 5B and 5C). A similar sustained
capacity of the DC to activate iNKT cells ex vivo was observed
with cells from C-glycoside-injected mice, although its antigenic
potency was reduced.
The CD1d-SMC124 Complex Affinity for the iNKT TCR
The potency of iNKT antigens is generally correlated to their
affinity for the TCR (Wang et al., 2010; Wun et al., 2011). Equilib-
rium binding analysis using surface plasmon resonance (SPR)
demonstrated a binding affinity (KD) of the iNKT TCR for CD1d-
SMC124 complexes of 51.9 ± 6.6 nM (Figure 6A). This is a binding
affinity similar to that observed with aGalCer (KD = 24.6 nM (data
not shown). The kinetic parameters revealed that the TCR binds
CD1d-SMCwith an association-rate 2-fold weaker than aGalCer
(ka = 4.25 ± 0.46 3 10
4 M-1 s-1), whereas the dissociation-rate
(kd = 2.2 ± 0.52 3 10
3 s-1) is similar to that seen with aGalCer
(ka = 7.84 3 10
4 M-1 s-1 and kd = 1.61 3 10
3 s-1, respectively;
data not shown).
Crystal Structure of the TCR-SMC-CD1d Ternary
Complex
In order to determine how the structural features of the plakoside
compound might affect binding to CD1d and recognition by the
iNKT TCR, we determined the structure of the CD1d-SMC124-
TCR complex by X-ray crystallography. The complex crystallized
in space group P21 with two complexes in the asymmetric unit.
Although differences are observed between the two noncrystal-
lographic symmetry-related molecules in correspondence to the
a3 domain of the CD1d molecule, the overall structure and theserved
Figure 6. Biophysical and Structural Char-
acterization of the CD1d-SMC124-iNKT
TCR Interaction
(A) Biacore sensorgram showing the binding of
increasing concentrations of TCR (0.004 to 1 mM)
to mouse CD1d-SMC124.
(B) Overall structure of the ternary complex CD1d-
SMC124-iNKT TCR. SMC124, yellow; CD1d
heavy chain and b2-microglobulin chain, gray;
TCR a chain, cyan; TCR b chain, orange.
(C) Stereo image of the 2FoFc electron density
map of the ligand. Themap is contoured at 1 s and
shown as a blue mesh around the ligand (in yellow)
in side view with the a2 helix removed for the
purpose of clarity. The cyclopropane modification
on the sphingoid base is shown in green. See also
Figure S3.
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to be very well conserved in both complexes. For this reason,
only one complex (chains A–D) will be described throughout
the text.
The overall structure of the CD1d-SMC124-iNKT TCR com-
plex is consistent with the structure of previously described
CD1d-lipid-iNKT TCR complexes (Figure 6B) (Li et al., 2010b;
Pellicci et al., 2009). The TCR docks in a parallel orientation on
top of the CD1d antigen binding groove, deviating significantly
from the diagonal footprint generally observed for MHC-
peptides-TCR complexes (Rudolph et al., 2006). The interaction
of the TCR with CD1d is mediated by residues in the CDR3a and
CDR2b loops and a CDR3b-dependent contact, as observed for
other ternary complexes obtained using the same iNKT TCR
construct (Aspeslagh et al., 2011; Li et al., 2010b). Well-defined
density is observed to correspond to the SMC124molecule (Fig-
ure 6C; Figure S3), suggesting an overall ordered conformation
of the ligand in the binding groove, with its galactose moiety
exposed for recognition by the TCR. Several polar interactions
between the polar moieties of the ligand and CD1d, involving
residues Glu80, Glu15, and Thr156 (Figures 7A and 7B),
contribute to the stabilization of the SMC124 conformation at
the top of the binding groove. Similarly, conserved hydrogen
bonds with CDR1a and CDR3a residues determine the modality
of interaction of the SMC124 galactose moiety with the iNKT
TCR (Figures 7C and 7D), as previously observed for aGalCerChemistry & Biology 18, 1620–1630, December 23, 2011 ªand other galactose-containing glyco-
lipids (Aspeslagh et al., 2011; Li et al.,
2010b; Wun et al., 2011).
Whereas the recognition constraints
imposed by the iNKT TCR lock the galac-
tose moiety of SMC124 in a conformation
virtually identical to the one observed for
aGalCer, differences are observed for
the lipid moiety. SMC124 binds similarly
to other sphingolipids, with its sphinga-
nine in the F0 pocket and the acyl chain
in the A0 pocket (Figures 7E and 7F).
Furthermore, when the structure of the
complexed SMC124 and aGalCer or Gal-
AGSL are superposed, in the A0 pocket
the acyl chain adopts a very similar conformation. However,
the longer sphingoid base of SMC124 is forced to adopt
a more compact conformation in the F0 pocket, extending to
the same depth in the pocket as GalAGSL and deeper than
aGalCer (Figures 7E and 7F; Figure S4). Interestingly, whereas
the region defining the bottom of the F0 pocket (residues
89–94) is not modeled in the CD1d-aGalCer-TCR complex, this
loop is ordered in the CD1d-GalAGSL-TCR and CD1d-
SMC124-TCR complexes, and it adopts the same conforma-
tion in both structures (Figure S4). Additionally, despite the
comparable number of contacts mediated by the SMC124
and aGalCer sphingoid bases with the residues lining the F0
pocket (32 van der Waals contacts for SMC124 and 34 for
aGalCer; Table S1), differences are observed between the
two compounds in terms of the residues involved. For example,
there is a unique interaction of the SMC124 sphingoid base
with the hydrophobic portion of the Glu92 side chain (Figures
7E and 7F). There are also some differences in the number of
contacts mediated by each interacting residue. This is seen in
the increased number of interactions between Val118 and the
cyclopropane moiety of SMC124. The compressed binding
of SMC124 in the CD1d binding groove results in an increased
buried surface area compared to aGalCer (1099 A˚2 vs.
1027 A˚2), as calculated by the PISA server, which could
increase the stability of the CD1d-SMC124 complex (Krissinel
and Henrick, 2007).2011 Elsevier Ltd All rights reserved 1625
Figure 7. Binding of SMC124 to CD1d
Top (A) and side (B) view of the SMC124-CD1d interactions. SMC124 is shown
in yellow. The cyclopropane modification on the SMC124 sphingoid base is
shown in green. Hydrogen bond interactions between CD1d residues and the
polar moieties of SMC124 are indicated with blue dashed lines.
(C and D) Contacts between SMC124 (C) and aGalCer (PDB ID 3HE6) (D) with
the iNKT TCR. The conserved hydrogen bonds with residues on the CDR1a
and CDR3a are shown as dashed blue lines with the corresponding distances
indicated in A˚. SMC124, yellow; aGalCer, orange; CD1d heavy chain, gray;
TCR a chain, cyan.
(E and F) Conformation of the sphingoid bases of SMC124 and aGalCer in the
F0 pocket. (E) Top view of the CD1d binding groove. (F) Side view of the binding
groove with the a2 helix removed for the purpose of clarity. SMC124 in yellow,
aGalCer in orange. Note the more tightly packed conformation of the longer
SMC124 sphingoid base in comparison to aGalCer. See also Figure S4 and
Tables S1 and S2.
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The ability to modify or identify iNKT cell antigens that instruct
either a Th1 or Th2 immune response is not only an area of active
investigation, but the development of such selective compounds
has potential therapeutic significance. Whereas the prototypical
iNKT cell ligand, aGalCer, is capable of strongly inducing both
Th1 and Th2 cytokines, a few variants have been developed
that skew toward either a Th1 or Th2 response (Arora et al.,
2011; Aspeslagh et al., 2011; Bendelac et al., 2007; Chang
et al., 2007; Im et al., 2009; Li et al., 2009; Li et al., 2010a; Tashiro
et al., 2010). To identify unique iNKT cell antigens that are
capable of providing both a Th1 response and activating human
iNKT cells, we synthesized lipid variants of aGalCer based on the1626 Chemistry & Biology 18, 1620–1630, December 23, 2011 ª2011structure of plakoside A, a naturally occurring glycosphingolipid
isolated from the marine sponge Plakortis simplex. Our studies
show that compounds with either the acyl chain or the sphingoid
base similar to plakoside A were capable of activating mouse
iNKT cells, and although they are less potent than aGalCer,
they cause a prolonged, systemic synthesis of IFN-g in vivo, in
part by enhanced trans activation of natural killer cells. Like the
prototypical Th1-skewing antigen C-glycoside, these com-
pounds predominantly are bound to CD1d molecules found in
lipid raft domains of the plasma membrane, and they exhibit
a prolonged ability to stimulate iNKT cells when tested ex vivo.
The similar properties exhibited by these three compounds
suggest that there could be general rules for the properties
required of Th1 cytokine-inducing glycolipid compounds. Unlike
C-glycoside, however, these plakoside-based antigens have the
ability to stimulate human iNKT cells.
In our study, skewing to a Th1 response in vivo was dependent
on an increased trans activation of natural killer cells, despite
decreased antigenic potency of the plakoside-like antigens early
after lipid injection. This downstream activation of natural killer
cells has been shown in other contexts to be dependent upon
the expression of CD40L by activated iNKT cells (Carnaud
et al., 1999; Yu and Porcelli, 2005). CD40L interacts with CD40
onDCandother APC, leading to the secretion of IL-12, a cytokine
that directly stimulates natural killer cells (Fujii et al., 2007).
Consistent with this mechanism, we observed increased induc-
tion of IL-12 in the sera 6–12 hr postinjection of the plakoside A
analogs. Furthermore, the ability of natural killer cells to be trans
activated by the plakoside A analogs, and therefore to skew
a Th1 response, required the expression of the IL-12Ra. Addi-
tionally, we propose that the events leading to enhanced IFN-g
secretion at 6 hr and beyond also require continuing iNKT cell
activation, which the ex vivo analysis suggests could be carried
out by APC exposed to the plakoside A analogs in vivo hours
earlier.
A prolonged activation of iNKT cells may depend on several
factors, including differences in intracellular trafficking of the
glycolipids, their ability to avoid degradation, and the stability
of their binding to CD1d. It has been clearly established that
lipid structure can influence the intracellular trafficking of lipids
(Mukherjee et al., 1999). Therefore, glycosphingolipids with dif-
ferent ceramide moieties would be differentially exposed to
degradative enzymes, whichmight affect their chemical stability.
In fact, C-glycoside was originally designed in an attempt to
identify a compound that would be resistant to degradation of
the O-glycosidic bond (Schmieg et al., 2003). Furthermore,
differential antigenic trafficking based on lipid structure also
could lead to loading into CD1d in different compartments of
the cell. CD1d molecules recycle between the plasma mem-
brane and various endosomal compartments, including lyso-
somes, and they can acquire antigens in intracellular compart-
ments, as well as on the cell surface. This could influence the
stability of the lipid/CD1d complex because of exposure, for
example, in lysosomes to lipid exchange and transfer proteins
(Bendelac et al., 2007). Furthermore, the endosomal site of
antigen loading could determine the ultimate localization of the
CD1d/antigen complex to plasma membrane microdomains,
and complexes located there could be more effective at antigen
presentation. Lipids that have shorter hydrophobic chains areElsevier Ltd All rights reserved
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but there is evidence that their binding to CD1d is destabilized in
the more acidic environment in late endosomes.2 Interestingly,
some compounds that skew a Th1 response tend to have a
longer acyl chain or sphingoid base, whereas truncation of these
hydrophobic chains has been shown to skew toward a Th2
response (Chang et al., 2007; Fujio et al., 2006; Goff et al.,
2004; Im et al., 2009; Li et al., 2010a;McCarthy et al., 2007;Miya-
moto et al., 2001; Oki et al., 2004; Yu et al., 2005).
Whereas lipid trafficking or the site of encounter with CD1d
could be important determinants of Th1 cytokine skewing,
our structural data suggest the hypothesis that enhanced
stability of binding to CD1d also could be important, at least
for SMC124, which has a larger area buried in the CD1d groove,
is located deeper in the groove, and causes a more ordered
conformation of the F0 pocket compared to bound aGalCer.
Recently, NU-aGalCer, a galactose modified aGalCer analog in
which the 6’’-OH group is replaced with a naphthylurea substit-
uent, was shown to have additional contacts with the CD1d
molecule, which might enhance the stability of binding (Aspe-
slagh et al., 2011). NU-aGalCer also causes a Th1 pattern of
cytokine production, consistent with the importance of the bio-
chemical stability of the glycolipid CD1d interaction in deter-
mining the Th1 cytokine profile.
The synthesis of the plakoside A analogs, SMC124 and EF77,
has added to the small number of Th1-biasing glycosphingoli-
pids that are capable of stimulating both mouse and human
iNKT cells. Furthermore, our mechanistic studies illuminate the
importance of the prolonged stimulation required to achieve sus-
tained IFN-g production in vivo and some of the factors required
to achieve it. It is remarkable that APC loaded with antigens,
such as SMC124, whose affinity of the TCR when bound to
CD1d is similar compared to aGalCer, have an increased ability
to stimulate iNKT cells approximately one day after injection.
Given this, we consider it likely that multiple factors are contrib-
uting to the ability of the plakoside A analogs to accumulate as
antigenic CD1d-complexes that can activate iNKT cells. Further
experiments will be required to determine if these compounds
behave similarly in human cells and if they can, in fact, be devel-
oped as effective antitumor agents or vaccine adjuvants.
SIGNIFICANCE
The number of glycolipids that bind CD1d and activate iNKT
cells is continually growing. These lipids include both natu-
rally occurring lipids and synthetic variants generated in an
attempt to modulate the immune response to one that is
beneficial to the host. Variations of the canonical iNKT cell
Ag, aGalCer, have led to Th1- or IFN-g-biasing conditions,
but a number of these antigens have proven ineffective in
activating human cells. Here, we have shown that structural
analogs of a naturally occurring glycolipid isolated from the
marine sponge Plakortis simplex, plakoside A, induce a
potent Th1-polarized immune response and are effective in
activating multiple human iNKT cell lines. These chemically
synthesized lipids contain a ceramide structure similar to
aGalCer but have unique lipid chains containing a cyclo-
propyl group on either the acyl chain or sphingoid base.
The ternary crystal structure of one of the lipids bound toChemistry & Biology 18, 1620–163CD1d in complex with iNKT cell TCR suggests that CD1d
can accommodate a long cyclopropyl containing sphingoid
base and this may lead to increased stability. Furthermore,
our biological assays indicate that these lipids have a pro-
longed biological stability, which likely accounts for the
potent trans activation of natural killer cells and the copious
amounts of IFN-g detected in the serum after lipid injection.
Additionally, our data suggests the plakoside A analogs are
associated with lipid-raft microdomains. These data have
revealed insights into the mechanisms that are necessary
in polarizing a Th-1 biased iNKT cell response. Additionally,
since our Plakoside A analogs efficiently activate human
iNKT cell lines, these antigens have therapeutic potential
where other Th1-biasing antigens have failed.
EXPERIMENTAL PROCEDURES
Chemical Synthesis
See the Supplementary Methods for synthetic procedures and characteriza-
tion data.
Generation of Human iNKT Cell Lines
Human Va24+ iNKT cells were purified and expanded in accordance with
published protocols (Rogers et al., 2004). Peripheral blood mononuclear
cells were isolated by density-gradient centrifugation. Human donor PBMC
(1–1.5 3 106/ml) were cultured in RPMI 1640 complete medium containing
10% autologous heat inactivated serum. Human iNKT cell cultures were ex-
panded by weekly re-stimulation with aGalCer-pulsed, irradiated PBMC and
recombinant human IL-2.
Antigen Presentation Assays
The antigen presentation assay has been described previously (Lawton et al.,
2005). Briefly, A20-CD1d cells were pulsed with vehicle or the indicated glyco-
sphingolipid overnight. APCs (1 3 105 per well) were incubated with 5 3 104
iNKT cell hybridomas for 20–24 hr. The DN3A4-1.2 (1.2) and DN3A4-1.4 (1.4)
Va14 iNKT cell hybridomas have been described previously (Brossay et al.,
1998). Cytokines in the supernatant of hybridoma cultures were measured
by a sandwich ELISA using anti-IL-2 monoclonal antibodies.
Cell-free Antigen Presentation Assay
Stimulation of iNKT cell hybridomas on microwell plates coated with soluble
CD1d was carried out in accordance with published protocols (Naidenko
et al., 1999; Sidobre et al., 2004; Tupin and Kronenberg, 2006). Indicated
amounts of compounds or vehicle were incubated for 24 hr in microwells
that had been coated with 1.0 mg of CD1d. After washing, 5 3 104 iNKT cell
hybridomas were cultured in the plate for 20 hr, and IL-2 in the supernatant
was measured by ELISA.
GM-CSF Production by Human Cells
Plakoside A or aGalCer-pulsed APCs (13 105 per well) were seeded in 96 well
plates and cultured in the presence of 5 3 104 Va24+ human iNKT cells for
20–24 hr. GM-CSF release was evaluated in a sandwich ELISA following the
manufacturer’s instructions (R&D Systems).
Mice
C57BL/6, and IL-12Ra/mice were purchased from the Jackson Laboratory.
All mice were housed in specific pathogen-free conditions, and the experi-
ments were approved by the Institutional Animal Care and Use Committee
of the La Jolla Institute for Allergy & Immunology. Mice were injected with
2 mg of lipids iv. As a positive control for iNKT cell responses, mice were
injected with 2 mg of aGalCer or C-Glycoside (Sullivan et al., 2010). Standard
sandwich ELISAs were performed to measure mouse IFN-g, IL-12p70, and
IL-4 in the sera of immunized mice.
Cell Preparation
Single-cell suspensions of splenocytes and liver lymphocytes were isolated as
described previously (Tyznik et al., 2008). For DC isolation from the spleen, the0, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1627
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and DCs were enriched by positive selection using a CD11c+ isolation kit with
RoboSep technology in accordance with the manufacturer’s protocols (Stem
Cell Technologies). Isolated DCs were cocultured at varying concentrations
with hybridomas overnight.
Flow Cytometry and Intracellular Cytokine Staining
Lymphocytes were stained with aGalCer/CD1d tetramers labeled with
streptavidin-allophycocyanin, anti-NK1.1-PerCp PE-cyanin (PECy)5, anti-
CD8-PECy7, anti-CD11b-PECy7, and anti-TCRb-allophycocyanin-AF750. All
antibodies and isotype controls were purchased from BD Biosciences, except
anti-TCRb-allophycocyanin-AF750 were obtained from eBioscience. Cells
were fixed and permeabilized using Cytofix/Cytoperm buffer and stained for
intracellular IFN-g with PE-labeled clone XMG1.2. The data were collected
on a LSR II and FACsCanto flow cytometer (BD Biosciences) and analyzed
using FlowJo software (Tree Star).
FACS-based Detergent Resistance Assay
All screening experiments were performed as previously described (Arora
et al., 2011). Briefly, JAWS II cells were seeded in U bottom 96well plates. Cells
were cultured with 100 nM concentration of each of the different glycolipid
analogs or controls. After 16 hr of culture, cells were detached, washed three
times, and resuspended in 50 ml of FACS buffer. After 10 min of incubation,
50 ml of staining solution containing 1 mg/ml of Alexa Flour 647 conjugated
mAB L363 in FACS buffer was added and followed by 10 min of incubation
on ice. Cells were washed and analyzed on a FACS Calibur flow cytometer
(BD Biosciences) with Cell Quest software. For estimation of lipid raft resi-
dency, the FACS analysis was performed in a kinetic mode. In the acquisition
mode, the beginning fluorescence level was recorded for 10 s. Triton X-100
was then added to a final concentration of 0.06% and followed by brief
(1 s) vortexing to mix the sample. Data collection was then resumed, and
fluorescence intensities were monitored for another 30 s. Data were collected
as flow cytometry standard files and analyzed using FlowJo software 7.5
(Treestar, Ashland, OR). Mean fluorescent intensity values at time 0 (prior to
addition of Tx-100) were normalized to 100, and relative decrease in MFI
values for different agonists after addition of Tx-100 were compared.
Mouse CD1d Expression, Purification, and Va14-Vb8.2 TCR
Refolding
Mouse CD1d-b2-microglobulin heterodimeric protein was expressed in a
baculovirus expression system as reported previously (Zajonc et al., 2005).
The TCR construct design, refolding, and purification processes were identical
to the ones previously reported (Wang et al., 2010).
Glycolipid Loading and SMC124-CD1d-TCR Complex Formation
The SMC124 lipid was dissolved in DMSO at 1mg/ml. Before loading, 60 ml of
the SMC124 solution was diluted to 0.25 mg/ml with 60 ml vehicle solution
(50 mM Tris-HCl pH 7.0, 4.8 mg/ml sucrose, 0.5 mg/ml sodium deoxycholate,
and 0.022% Tween 20) and 120 ml 10 mg/ml Tween 20, followed by incubation
at 80C for 20 min. SMC124 was loaded onto CD1d by incubating CD1d and
the lipid (molar ratio of protein to lipid of 1:3) overnight in the presence of
50 mM Tris-HCl pH 7.0. For CD1d-TCR complex formation, the refolded
TCR was incubated at room temperature for 30 min with lipid-loaded CD1d
at a 1:2 molar ratio, as the SMC124 loading efficiency is approximately 50%,
which was measured using the aGalCer specific antibody L317 (Yu et al.,
2007) in a SPR binding experiment. The ternary CD1d-lipid-TCR complex
was isolated from uncomplexed CD1d and TCR by size exclusion chromatog-
raphy using Superdex S200 10/300 GL (GE Healthcare).
SPR Binding Analysis
SPR binding studies were conducted using a Biacore 3000 (Biacore) as
reported previously (Wang et al., 2010). Recombinant CD1d protein containing
a birA-tag (LHHILDAQKMVWNHR) between the CD1d ectodomain and
C-terminal hexahistidine tag was expressed and purified as reported above
for the non-birA-tagged CD1d. Pure birA-tagged CD1d was biotinylated using
a commercial biotinylation kit (Avidity) and then isolated from free biotin on
Superdex S200 10/300 GL. The lipid was loaded to biotinylated birA-tagged
CD1d in the same way as non-birA-tagged CD1d. Three hundred response1628 Chemistry & Biology 18, 1620–1630, December 23, 2011 ª2011units of CD1d-SMC124 were immobilized onto a streptavidin sensor chip
(Biacore) surface by injecting the CD1d-SMC124 mixture at 5 ml/min (HBS
running buffer without Tween 20 to prevent or slow down the washing of the
glycolipid off CD1d: 10 mM HEPES, 150 mM NaCl, 3.0 mM EDTA, pH 7.4).
A reference surface was generated in another flow channel with unloaded
CD1d. During the association phase, a series of increasing concentrations of
TCR in duplicate were injected for 2 min, and the dissociation phase, initiated
by passage of running buffer alone, was continued over 45 min. Experiments
were carried out at 25C with a flow rate of 30 ml/min and were performed at
least two times. Kinetic parameters were calculated after subtracting the
response to CD1d molecules in the reference channel, using a simple Lang-
muir 1:1 model in the BIAevaluation software version 4.1. One representative
sensorgram is shown.Crystallization and Structure Determination
The CD1d-SMC124-TCR complex was isolated by Superdex S200 10/300 GL
(GE Healthcare) equilibrated in buffer (50 mM HEPES [pH 7.4], 150 mM NaCl).
The fractions containing the complex were concentrated to 5 mg/ml. Crystals
were grown at 22.3C by sitting drop vapor diffusion, while mixing 0.5 ml
protein with 0.5 ml precipitate (100mM trisodium citrate [pH 5.6], 10%
PEG3350, and 2% tacsimate [pH 5.0]). Crystals were then flash-cooled at
100 K inmother liquor containing 20%glycerol. Diffraction data were collected
at the Stanford Synchrotron Radiation Laboratory beamline 9.2 and processed
with the software Mosflm (Leslie, 2006). The CD1d-SMC124-TCR crystallized
in space group P21 (unit cell dimensions: a = 79.0 A˚; b = 150.6 A˚; c = 102.0;
A˚ b = 96.3). In the crystal, two CD1d-SMC124-TCR complexes occupy
the asymmetric unit. The structure was solved by molecular replacement in
CCP4 (Collaborative Computational Project, Number 4; 1994) using the protein
coordinates from the CD1d-iGB3 structure (Protein Data Bank [PDB] code
2Q7Y) (Zajonc et al., 2008) as the search model followed by the iNKT TCR
(PDB code 3HE6) (Pellicci et al., 2009). Themodel was rebuilt into sA-weighted
2Fo –Fc and Fo – Fc difference electron density maps using the program
COOT (Emsley et al., 2010). The lipid was built into 2Fo –Fc map and refined
using REFMAC (Collaborative Computational Project, Number 4, 1994). The
final refinement steps were performed using the TLS procedure in REFMAC
with five domains (a1-a2 domain, including carbohydrates and glycolipid,
a3-domain, b2 m, variable domain, and constant domain of TCR). The
CD1d-SMC124-TCR structure was refined to 2.8 A˚ to an Rcryst and Rfree of
22.6% and 27.3%, respectively. The quality of the model was excellent as
assessed with the program Molprobity (Lovell et al., 2003). Data collection
and refinement statistics are presented in Table S2.Statistical Analysis
An unpaired independent samples t test was used for analysis of two separate
sets of independent and identically distributed samples. Analysis was for equal
variance. Normality was confirmed with a Kolmogorov-Smirnov test.ACCESSION NUMBERS
Structure factors and coordinates have been deposited in the Protein Data
Bank under accession code 3TVM.SUPPLEMENTAL INFORMATION
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